Keywords
Penile implant, penile glans enhancement, penile venous stripping,
prosthesis extrusion, soft glans syndrome, shrinkage glans penis
INTRODUCTION
In 1998, the first agent of PDE-5 inhibitor was available to treat
patients who have erectile dysfunction regardless of varied underlying
causes (ED).1 Subsequently, this type of agent opened
the era of medical treatment as the first line of options for these
awkward diseases.2,3 The second-line varied treatment
strategy will be resorted if patients are poorly responsive to the
oral PDE-5 inhibitors.4 These second-line options
include vacuum constriction devices, vasodilator intracorporeal
injection, endovascular therapies entailing sclerotherapy, and
controversial penile vascular surgery.5 Although no
sustainable scientific support exists, resulting in none that the
Federal Drug Administration has proved in the United States, recent
popularity has soared among marketers. There are many, such as
extracorporeal shock wave therapy (ESWT) supported by randomized
studies,6 platelet-rich plasma (PRP) injection, stem
cell injection, etc. Still, the penile implant remains a golden solution
for those patients whose erection dysfunction has been
refractory.7
Some complications in this golden standard option appear unavoidable,
such as shrined soft glans syndrome, mechanical failure, intracorporeal
infection, and prosthesis extrusion, which is the most
hazardous.8 These issues might suffer psychologically,
but not just physically, for patients who underwent a prior penile
implant, particularly the most typical issue of soft glans syndrome
complained about by their sexual partner. We report an example case of
suffering from soft glans syndrome with impending prosthesis loss in his
sixth journey of penile implantation. However, he is unaware of an
imminent prosthesis loss on the patient’s side. Given appropriate
housing, a penile implant was published in 1994;9 this
surgery niche has not been popularly recognized in the urology
profession; we sought to report this case in solving the shrinkage soft
glans syndrome and implant malposition with a novel enhancement
strategy,10 in addition to repositioning the implant
on an ambulatory basis.